DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Ubicación actual:
> This Story

Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment


Molecular Imaging Homepage

Global PET/CT scanner market projected to reach $2.1 billion by 2023 Growth spurred in part by increased Medicare coverage

Can theranostics be the key to completely curing colorectal cancer? Preclinical trials yield promising results

Cerveau Technologies to collaborate in development of PET imaging agents for Alzheimer’s disease

MJFF and Tau Consortium partner to accelerate the development of new PET tracers May detect early stage neurodegenerative disease

Cerveau inks deal with AbbVie for investigational tau imaging PET agent Stage III clinical trial to begin in next few months

New molecular imaging technology for prostate cancer may improve surgical outcomes Lightpoint Medical forges new partnerships

Phase I trial demonstrates safe use of radiotracer produced in minutes Manufactured using a Ga-68 generator and a cold kit vial

Bracco Imaging acquires SurgVision Enables development of a real-time fluorescence image-guided surgery platform

Blue Earth Diagnostics inks Axumin deal with Seibersdorf Laboratories Manufacturing and distribution in certain European countries

Two new imaging agents may help physicians make better and quicker treatment decisions Could determine therapy response in 24 hours

Using cryo-MOST, the researchers
acquired a brain-wide map of an
Alzheimer mouse model showing
that senile plaques
had spread to the entire brain

New imaging system may accelerate drug development for Alzheimer's

por Lauren Dubinsky , Senior Reporter
Researchers in China developed a new imaging system that has the potential to accelerate drug development for Alzheimer's disease.

Cryo-micro-optical sectioning tomography is a better alternative for monitoring brain changes associated with the disease in mouse models, according to a study published in Optics Letters.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory

"We tried to observe the redox state of Alzheimer's in mouse brain [models] and found some interesting new phenomena," Jing Yuan, one of the researchers, told HCB News. "[We wondered] if there was any other useful autofluorescence we could find from tissue and then began this new project."

Mice are valuable for studying the biology of Alzheimer's and testing new drugs because proteins called senile plaques accumulate in both human and mice brains. The cryo-MOST system was designed to better image those proteins in the whole mouse brain.

Since it's optical, the cryo-MOST system generates more detailed information than other imaging modalities such as MR and PET. It also doesn't require external dyes or labels because it takes advantage of the natural fluorescence of senile plaques after exposure to excitation light.

For the study, Yuan and his team used cryo-MOST to image the whole brain of a 17-month mouse with Alzheimer's. The images revealed that senile plaques had spread to the whole brain.

That indicates that the disease doesn't only affect memory and intelligence, but might also lead to the deterioration of other brain functions.

In the case of humans, the cryo-MOST system can only be used to study deceased donors since the size of the tissue imaged is limited by the maximum moving range of the mechanical stage. It may also be useful for visualizing other biological molecules that exhibit autofluorescence in the kidney and liver.

The research team is currently working to improve the system's automation in order to accelerate image acquisition, and making enhancements that will improve image quality. That will enable the system to be used for more applications.

They are also continuing their research into studying senile plaque distribution and morphology changes as a result of Alzheimer's progression.

When asked if cryo-MOST will eventually become the standard for studying Alzheimer's, Yuan said that it has potential.

"Taking advantage of simple sample preparation, intrinsic autofluorescence, whole-brain imaging range and micron-level resolution, cryo-MOST [could] potentially become a useful research tool and standard for studying Alzheimer's," he added.

Back to HCB News
  Pages: 1

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment

Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2017, Inc.